Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1101–1150 of 76231
On July 2, 2026, André Branch informed the Board of Directors (the “Board”) of Signet Jewelers Limited (the “Company”) of his decision to resign as a director of the Board, effective immediately.
On July 2, 2026, the Company also announced the appointment of Mark Pauls as Chief Operating Officer of the Company, effective July 15, 2026.
On July 1, 2026, Six Flags Entertainment Corporation (the “Company”) announced Tim Fisher’s departure from the role of Chief Operating Officer of the Company, effective July 15, 2026.
Mr. McGee is stepping down for personal reasons and not due to any disagreement with the Company or any matter relating to Grayscale’s operations, policies or practices.
the appointment of Ms. Masci as a member of the Board of Managers of Grayscale Investments Sponsors, LLC
the appointment of Kathryn Masci, Senior Vice President, Finance, and Daniel Plourde, Senior Vice President, Finance, to serve as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026
the appointment of Kathryn Masci, Senior Vice President, Finance, and Daniel Plourde, Senior Vice President, Finance, to serve as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026
the appointment of Ms. Masci as a member of the Board of Managers of Grayscale Investments Sponsors, LLC.
the appointment of Kathryn Masci, Senior Vice President, Finance, and Daniel Plourde, Senior Vice President, Finance, to serve as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026
Mr. McGee is stepping down for personal reasons and not due to any disagreement with the Company or any matter relating to Grayscale’s operations, policies or practices.
the appointment of Kathryn Masci, Senior Vice President, Finance, and Daniel Plourde, Senior Vice President, Finance, to serve as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026
Mr. McGee is stepping down for personal reasons and not due to any disagreement with the Company or any matter relating to Grayscale’s operations, policies or practices.
the appointment of Kathryn Masci, Senior Vice President, Finance, and Daniel Plourde, Senior Vice President, Finance, to serve as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026
the appointment of Ms. Masci as a member of the Board of Managers of Grayscale Investments Sponsors, LLC.
Kevin Shannon was appointed as Chief Executive Officer of Inflection Point.
Effective June 26, 2026, Gary Quin resigned as Chairman and Chief Executive Officer of Inflection Point
Effective June 26, 2026, Gary Quin was appointed as President of Inflection Point.
Michael Blitzer was appointed as director and Chairman of the Board of Directors
Effective June 26, 2026, Gary Quin resigned as Chairman and Chief Executive Officer of Inflection Point
Effective July 1, 2026, the Board of Directors of Live Oak Bancshares, Inc., (the “Company”) appointed Mr. Diffley as the Company’s Principal Accounting Officer (“PAO”).
Mr. Diffley replaces Walter J. Phifer who served as interim PAO of the Company since June 16, 2026, as previously announced.
the Board of Directors (the “Board”) of the Company has elected Shawn P. Payne as a Director of the Company effective July 1, 2026
On July 1, 2026, the Board of Directors (the “Board”) of CapsoVision Inc. (the “Company”) appointed Dr. David Stanley Shields to serve as a Class I director of the Board and as a member of the Compensation Committee of the Board
On July 1, 2026, Dr. Joanne Imperial stepped down from the Board as a Class I director and as a member of the Compensation Committee of the Board, effective immediately.
On June 30, 2026, Sean McNealy notified the Company of his decision to resign from his role as a director of the Company, effective June 30, 2026, in connection with his planned retirement.
On June 28, 2026, Ajay K. Puri, Executive Vice President, Worldwide Field Operations of NVIDIA Corporation, or the Company, notified the Company of his intention to retire from his role effective upon the employment commencement date of his successor.
On July 1, 2026, the Company appointed Nicholas Parker, age 55, as Executive Vice President, Worldwide Field Operations of the Company, effective upon the commencement of his employment with the Company, which is anticipated to be on August 24, 2026.
On July 1, 2026, the Company’s Board of Directors (the “ Board ”) appointed Alexander De Bock as its incoming Chief Financial Officer.
Taoufiq Boussaid, the Company’s current Chief Financial Officer will leave the Company after a transition period following the Company’s Q2 2026 earnings.
the Board accepted the resignation of Cao Zhi Fen as the director, president, Chief Executive Officer, treasurer and secretary of the Company, and concurrently appointed Mr. David I. Rosenberg as a director and the Chairman of the Board and Mr. John Lipman as the Chief Executive Officer, Chief Financial Officer and director of the Company, each effective as of the Closing and until their earlier death, disqualification, resignation or removal.
the Board accepted the resignation of Cao Zhi Fen as the director, president, Chief Executive Officer, treasurer and secretary of the Company, and concurrently appointed Mr. David I. Rosenberg as a director and the Chairman of the Board and Mr. John Lipman as the Chief Executive Officer, Chief Financial Officer and director of the Company, each effective as of the Closing and until their earlier death, disqualification, resignation or removal.
the Board accepted the resignation of Cao Zhi Fen as the director, president, Chief Executive Officer, treasurer and secretary of the Company, and concurrently appointed Mr. David I. Rosenberg as a director and the Chairman of the Board and Mr. John Lipman as the Chief Executive Officer, Chief Financial Officer and director of the Company, each effective as of the Closing and until their earlier death, disqualification, resignation or removal.
On June 26, 2026, the Board of Directors (the “Board”) of Reinsurance Group of America, Incorporated (the “Company”) appointed Maurice Tulloch to the Board, effective July 1, 2026, for a term of office ending at the 2027 annual meeting of shareholders, or until his successor is duly elected and qualified.
the Amendment provides that the term of Mr. Fisher’s Employment Agreement will expire on December 15, 2026
On June 29, 2026, Mr. Schaap was appointed to serve on the Board.
On July 1, 2026, The Williams Companies, Inc. (“the Company”) announced that Robb E. Turner and Lloyd W. (Billy) Helms, Jr., have been appointed to the Company’s Board of Directors, effective July 1, 2026.
On July 1, 2026, The Williams Companies, Inc. (“the Company”) announced that Robb E. Turner and Lloyd W. (Billy) Helms, Jr., have been appointed to the Company’s Board of Directors, effective July 1, 2026.
On June 26, 2026, Mr. Michael Goettler notified Bausch Health Companies Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”), effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.
On July 1, 2026, Employers Holdings, Inc. (“EHI” or the “Company”) announced that on June 25, 2026, Stephanie C. Bush was elected to the EHI Board of Directors (the “Board”), with her term of service commencing on July 1, 2026.
In connection with the retirement of Joseph M. Viselli, as previously disclosed in TopBuild’s Current Report on Form 8-K filed with the SEC on April 17, 2026, in recognition of his contributions to TopBuild and in consideration of his ongoing restrictive covenants and other post-employment obligations, on June 30, 2026, the Compensation Committee of TopBuild’s board of directors approved a cash payment to Mr. Viselli in the amount of $894,539, less applicable taxes and withholdings (the “Cash Payment”).
Effective July 31, 2026, in connection with the closing of the Transaction, Chris T. Bitterman, Vice President Sales & Marketing, and James L. Herman, Vice President Trade & Distribution and Corporate Compliance Officer, will resign from the Company and will be hired by an affiliate of Apotex.
Effective July 31, 2026, in connection with the closing of the Transaction, Chris T. Bitterman, Vice President Sales & Marketing, and James L. Herman, Vice President Trade & Distribution and Corporate Compliance Officer, will resign from the Company and will be hired by an affiliate of Apotex.
On June 30, 2026, of X4 Pharmaceuticals, Inc. (the “Company”) appointed Kelly Gold as a Class II director of the Company, effective as of July 1, 2026.
In connection with her appointment, Dr. Hannah resigned from the Company’s Board of Directors (the “Board”), effective July 1, 2026.
On July 1, 2026, Rigel Pharmaceuticals, Inc. (the "Company") announced that Alison L. Hannah, M.D. was appointed Executive Vice President and Chief Medical Officer of the Company.
Effective June 25, 2026, Lisa Rojkjaer, M.D. ceased serving as Executive Vice President and Chief Medical Officer of the Company and separated from the Company.
On July 1, 2026, the Board of Directors of BAB, Inc. (the "Company") elected George M. Ristau, Jr. to serve as a member of the Board of Directors, filling the vacancy created by the passing of James A. Lentz, and he will serve until the Company's 2027 Annual Meeting of Shareholders.
appointed Andrew (Andy) Reding to serve as Executive Vice President, Chief Operating Officer (“COO”) of the Company, effective July 6, 2026.
appointed Bruce Hausmann to serve as a director of the Company, effective July 1, 2026
In connection with his retirement, on June 30, 2026, Mr. Berges and FirstBank Puerto Rico, a subsidiary of the Corporation entered into a Professional Services Agreement
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.